Impact of the Radiation Dose and Completion of Palliative Radiotherapy on Survival in Patients Treated for Locally Advanced Lung Cancer

Stefan Janssen, Lukas Kaesmann, Steven E. Schild, Dirk Rades

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

AIM: To compare three total radiation dose levels for their impact on survival in patients receiving palliative radiotherapy (RT) for locally advanced lung cancer.

PATIENTS AND METHODS: Radiation dose (equivalent dose in 2 Gy fractions=EQD2: 31-40 Gy vs. 41-46 Gy vs. 47-52 Gy), completion of RT as planned, plus nine factors were analyzed for survival in 125 patients.

RESULTS: On multivariate analysis, EQD2 47-52 Gy (p=0.018), completion of planned RT (p=0.002), lower T-category (p=0.027) and lower N-category (p=0.008) were positively associated with survival. Thirty-six patients (29%) could not receive the complete planned RT dose, 19% in the 31-40 Gy group, 36% in the 41-46 Gy group and 31% in the 47-52 Gy group, respectively. Six-month survival rates of these patients were 0%, 18% and 18%, respectively.

CONCLUSION: Higher RT doses resulted in significantly better survival than lower doses. The favorable results were impaired when the planned treatment could not be completed.

Original languageEnglish (US)
Pages (from-to)1825-1828
Number of pages4
JournalAnticancer Research
Volume36
Issue number4
StatePublished - Apr 1 2016

Fingerprint

Lung Neoplasms
Radiotherapy
Radiation
Survival
Multivariate Analysis
Survival Rate
Therapeutics

Keywords

  • Advanced lung cancer
  • completion of treatment
  • palliative radiation therapy
  • radiation dose
  • survival

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Cancer Research

Cite this

Impact of the Radiation Dose and Completion of Palliative Radiotherapy on Survival in Patients Treated for Locally Advanced Lung Cancer. / Janssen, Stefan; Kaesmann, Lukas; Schild, Steven E.; Rades, Dirk.

In: Anticancer Research, Vol. 36, No. 4, 01.04.2016, p. 1825-1828.

Research output: Contribution to journalArticle

Janssen, Stefan ; Kaesmann, Lukas ; Schild, Steven E. ; Rades, Dirk. / Impact of the Radiation Dose and Completion of Palliative Radiotherapy on Survival in Patients Treated for Locally Advanced Lung Cancer. In: Anticancer Research. 2016 ; Vol. 36, No. 4. pp. 1825-1828.
@article{e57c0cd791924452b38076699c70b2b9,
title = "Impact of the Radiation Dose and Completion of Palliative Radiotherapy on Survival in Patients Treated for Locally Advanced Lung Cancer",
abstract = "AIM: To compare three total radiation dose levels for their impact on survival in patients receiving palliative radiotherapy (RT) for locally advanced lung cancer.PATIENTS AND METHODS: Radiation dose (equivalent dose in 2 Gy fractions=EQD2: 31-40 Gy vs. 41-46 Gy vs. 47-52 Gy), completion of RT as planned, plus nine factors were analyzed for survival in 125 patients.RESULTS: On multivariate analysis, EQD2 47-52 Gy (p=0.018), completion of planned RT (p=0.002), lower T-category (p=0.027) and lower N-category (p=0.008) were positively associated with survival. Thirty-six patients (29{\%}) could not receive the complete planned RT dose, 19{\%} in the 31-40 Gy group, 36{\%} in the 41-46 Gy group and 31{\%} in the 47-52 Gy group, respectively. Six-month survival rates of these patients were 0{\%}, 18{\%} and 18{\%}, respectively.CONCLUSION: Higher RT doses resulted in significantly better survival than lower doses. The favorable results were impaired when the planned treatment could not be completed.",
keywords = "Advanced lung cancer, completion of treatment, palliative radiation therapy, radiation dose, survival",
author = "Stefan Janssen and Lukas Kaesmann and Schild, {Steven E.} and Dirk Rades",
year = "2016",
month = "4",
day = "1",
language = "English (US)",
volume = "36",
pages = "1825--1828",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "4",

}

TY - JOUR

T1 - Impact of the Radiation Dose and Completion of Palliative Radiotherapy on Survival in Patients Treated for Locally Advanced Lung Cancer

AU - Janssen, Stefan

AU - Kaesmann, Lukas

AU - Schild, Steven E.

AU - Rades, Dirk

PY - 2016/4/1

Y1 - 2016/4/1

N2 - AIM: To compare three total radiation dose levels for their impact on survival in patients receiving palliative radiotherapy (RT) for locally advanced lung cancer.PATIENTS AND METHODS: Radiation dose (equivalent dose in 2 Gy fractions=EQD2: 31-40 Gy vs. 41-46 Gy vs. 47-52 Gy), completion of RT as planned, plus nine factors were analyzed for survival in 125 patients.RESULTS: On multivariate analysis, EQD2 47-52 Gy (p=0.018), completion of planned RT (p=0.002), lower T-category (p=0.027) and lower N-category (p=0.008) were positively associated with survival. Thirty-six patients (29%) could not receive the complete planned RT dose, 19% in the 31-40 Gy group, 36% in the 41-46 Gy group and 31% in the 47-52 Gy group, respectively. Six-month survival rates of these patients were 0%, 18% and 18%, respectively.CONCLUSION: Higher RT doses resulted in significantly better survival than lower doses. The favorable results were impaired when the planned treatment could not be completed.

AB - AIM: To compare three total radiation dose levels for their impact on survival in patients receiving palliative radiotherapy (RT) for locally advanced lung cancer.PATIENTS AND METHODS: Radiation dose (equivalent dose in 2 Gy fractions=EQD2: 31-40 Gy vs. 41-46 Gy vs. 47-52 Gy), completion of RT as planned, plus nine factors were analyzed for survival in 125 patients.RESULTS: On multivariate analysis, EQD2 47-52 Gy (p=0.018), completion of planned RT (p=0.002), lower T-category (p=0.027) and lower N-category (p=0.008) were positively associated with survival. Thirty-six patients (29%) could not receive the complete planned RT dose, 19% in the 31-40 Gy group, 36% in the 41-46 Gy group and 31% in the 47-52 Gy group, respectively. Six-month survival rates of these patients were 0%, 18% and 18%, respectively.CONCLUSION: Higher RT doses resulted in significantly better survival than lower doses. The favorable results were impaired when the planned treatment could not be completed.

KW - Advanced lung cancer

KW - completion of treatment

KW - palliative radiation therapy

KW - radiation dose

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=84984550806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984550806&partnerID=8YFLogxK

M3 - Article

C2 - 27069165

AN - SCOPUS:84984550806

VL - 36

SP - 1825

EP - 1828

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 4

ER -